Study Shows Peritoneal Mesothelioma Surgery Underutilized

August 13, 2020 By Melissa Soria

The continued underutilization of aggressive surgery for peritoneal mesothelioma is shortening survival time dramatically for patients who could qualify for, and benefit from, the highly effective procedure. Only a third of those diagnosed with peritoneal mesothelioma are undergoing potentially curative cytoreductive mesothelioma surgery, according to a comprehensive study of the National Cancer Database by researchers at…

Cryoablation Study for Mesothelioma Opening at UCLA

August 12, 2020 By Melissa Soria

Researchers at UCLA Jonsson Comprehensive Cancer Center will soon begin studying the pre-surgery use of cryoablation as a potential early adjuvant therapy for patients with pleural mesothelioma. The pilot study will measure immune system stimulation through local tumor infiltration in hopes of extending patient survival in the future. Cryoablation, also known as cryotherapy or cryosurgery, freezes…

Mesothelioma Clinical Trials Now Back on Course

August 11, 2020 By Melissa Soria

A number of treatment centers, such as Brigham and Women’s Hospital in Boston, delayed mesothelioma clinical trials at the start of the pandemic. Others, such as the Pacific Mesothelioma Center in Los Angeles, continued screening patients, but on a limited basis. Now, many mesothelioma clinical trials are resuming regular screening and enrollment measures for mesothelioma patients…

24-Hour Flash Sale for the virtual MRFJ 5K starts today at noon!

July 31, 2020 By Melissa Soria

Get 50% off our upcoming virtual Mesothelioma Race for Justice 5K! The flash sale begins Friday, July 31, at noon, and ends Saturday, Aug. 1, at noon. Use the code HALFOFF during registration. Proceeds from the virtual 5K will go to the Mesothelioma Applied Research Foundation (MARF). Participants will have the month of September to…

New Mesothelioma Clinical Trial Involves Keytruda

July 22, 2020 By Melissa Soria

Standard-of-care treatment for malignant mesothelioma could change significantly, depending upon the results of an upcoming clinical trial of two immunotherapy agents used in combination with chemotherapy. The clinical trial will involve pembrolizumab, also known by the brand name Keytruda and its synergy with ONCOS-102, a lesser-known, genetically modified adenovirus. Individually, both have shown modest efficacy for mesothelioma…

Discounts Available for This Year’s Virtual MRFJ 5K!

July 17, 2020 By Melissa Soria

Discounts are available for this year’s virtual MRFJ 5K! Create or join a friend’s MRFJ team and receive $5 off this year’s registration!   Or refer three friends to register for the 2020 MRFJ to receive half off the cost of the 2021 MRFJ registration! Here’s how: Visit the Promoter Dashboard at RaceRoster.com/dashboard/promoters  Share your unique promoter link (located below the event name) with…

Here’s what you should know about asbestos in your home

July 9, 2020 By Melissa Soria

You probably don’t think about asbestos exposure very often. The EPA banned its use in 1989, and after all the news articles about how asbestos causes cancer and mesothelioma, who would want to use it at all? But the ban was removed a few years later, and while contractors virtually never use asbestos in residential…

Bayer to Pay $10 Billion to Settle Roundup Lawsuits

June 25, 2020 By Melissa Soria

Bayer will pay more than $10 billion to resolve thousands of lawsuits regarding claims that its herbicide Roundup causes cancer, the company announced Wednesday. Monsanto, which Bayer bought in 2018, lost a lawsuit that same year brought by a school groundskeeper who claimed its weedkiller had caused his non-Hodgkin lymphoma. Since then, thousands of U.S. lawsuits have been…

Women With Cancer Awarded Billions in Baby Powder Suit

June 24, 2020 By Melissa Soria

A Missouri appeals court ordered Johnson & Johnson and a subsidiary to pay $2.1 billion in damages to women who blamed their ovarian cancers on the company’s talcum products, including its iconic baby powder. The decision slashed by more than half a record award of $4.69 billion in compensatory and punitive damages to the women,…

Load more